Search
Caris Life Sciences Inc
CAIAdd to Watchlist
15.039USD
-0.211-1.38%
Market hours （ET）Quotes delayed by 15 min
4.25BMarket Cap
LossP/E TTM
More Details of Caris Life Sciences Inc Company
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Caris Life Sciences Inc Info
Ticker SymbolCAI
Company nameCaris Life Sciences Inc
IPO dateJun 18, 2025
CEOHalbert (David Dean)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJun 18
Address750 W. John Carpenter Freeway
CityIRVING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code75039
Phone18667718946
Websitehttps://www.carislifesciences.com/
Ticker SymbolCAI
IPO dateJun 18, 2025
CEOHalbert (David Dean)
Company Executives of Caris Life Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
163.54K
+39.12%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
801.39M
98.69%
International
10.64M
1.31%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Halbert (David D)
43.52%
Sixth Street Partners, LLC
6.86%
J.H. Whitney Capital Partners, LLC
6.46%
J. H. Whitney Equity Partners VI, LLC
6.46%
Fidelity Management & Research Company LLC
4.48%
Other
32.23%
Shareholders
Shareholders
Proportion
Halbert (David D)
43.52%
Sixth Street Partners, LLC
6.86%
J.H. Whitney Capital Partners, LLC
6.46%
J. H. Whitney Equity Partners VI, LLC
6.46%
Fidelity Management & Research Company LLC
4.48%
Other
32.23%
Shareholder Types
Shareholders
Proportion
Individual Investor
48.53%
Investment Advisor
26.42%
Hedge Fund
13.90%
Private Equity
7.96%
Investment Advisor/Hedge Fund
5.69%
Research Firm
0.93%
Pension Fund
0.60%
Sovereign Wealth Fund
0.04%
Bank and Trust
0.03%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
228
134.49M
38.87%
--
2026Q1
348
157.12M
55.58%
+16.76M
2025Q4
261
137.01M
48.56%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Halbert (David D)
123.08M
43.56%
+320.11K
+0.26%
Mar 06, 2026
Sixth Street Partners, LLC
19.39M
6.86%
-5.00M
-20.50%
Dec 31, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.17%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
12.67M
4.48%
+3.09M
+32.26%
Dec 31, 2025
Castleman Peter M
10.38M
3.67%
+5.51K
+0.05%
Feb 26, 2026
Coatue Management, L.L.C.
9.82M
3.48%
-322.21K
-3.18%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
9.21M
3.26%
+1.18M
+14.71%
Dec 31, 2025
Braidwell LP
7.82M
2.77%
+500.00K
+6.83%
Dec 31, 2025
PointState Capital LP
6.72M
2.38%
+2.83M
+73.00%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
View more
ARK Genomic Revolution ETF
Proportion0.67%
Texas Capital Texas Small Cap Equity Index ETF
Proportion0.52%
Renaissance IPO ETF
Proportion0.43%
RiverNorth Patriot ETF
Proportion0.3%
Franklin Genomic Advancements ETF
Proportion0.29%
Invesco Russell 1000 Equal Weight ETF
Proportion0.08%
Inspire 500 ETF
Proportion0.07%
T Rowe Price Small-Mid Cap ETF
Proportion0.05%
Texas Capital Texas Equity Index ETF
Proportion0.04%
Fidelity Nasdaq Composite Index ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
